Tanios Bekaii-Saab, MD: Strategies to Increase RAS Testing
Watch
Tanios Bekaii-Saab, MD: Impeding RAS Mutation Testing
Tanios Bekaii-Saab, MD: Percentage of RAS Mutation Tests in Metastatic CRC
Tanios Bekaii-Saab, MD: RAS Mutations and the Sequence of Therapies
Tanios Bekaii-Saab, MD: Clinical Importance of RAS Mutations
Tanios Bekaii-Saab, MD: RAS Mutations in Metastatic Colorectal Cancer
Tanios Bekaii-Saab, MD: Mutations in Colorectal Cancer
Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD: Case 2
Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD
Unresectable Colon Cancer with Charles Fuchs, MD and Tanios Bekaii-Saab, MD: Case 1
Charles Fuchs, MD: Mutations in Colorectal Cancer
Charles Fuchs, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Charles Fuchs, MD: Treatment Toxicities and Quality of Life
Charles Fuchs, MD: Chemotherapy Side-Effects
Charles Fuchs, MD: Bevacizumab Side-Effects
Charles Fuchs, MD: Bevacizumab Plus Chemotherapy
Charles Fuchs, MD: First-Line Treatments in Unresectable Colon Cancer
Tanios Bekaii-Saab, MD: Experience With Patients on Bevacizumab Plus Chemotherapy
Tanios Bekaii-Saab, MD: Treatment Toxicities and Quality of Life
Tanios Bekaii-Saab, MD: Chemotherapy Side-Effects
Tanios Bekaii-Saab, MD: Bevacizumab Side-Effects
Tanios Bekaii-Saab, MD: Bevacizumab Plus Chemotherapy
Tanios Bekaii-Saab, MD: First-Line Treatments in Unresectable Colon Cancer
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD: Case 2
ER+/HER2-Breast Cancer with Adam Brufsky, MD, PhD and Kimberly Blackwell, MD
Adam Brufsky, MD, PhD: Clinical Trial Data Supporting These Choices
Adam Brufsky, MD, PhD: Expectations of Therapy in Breast Cancer
Adam Brufsky, MD, PhD: Considerations for Different Therapies in Breast Cancer
Adam Brufsky, MD, PhD: Choices of Therapy in Breast Cancer
Kimberly Blackwell, MD: Clinical Trial Data Supporting These Choices
Kimberly Blackwell, MD: Expectations of Therapy in Breast Cancer
Kimberly Blackwell, MD: Considerations for Different Therapies in Breast Cancer